Life Sciences

D&B David and Baias Advises Fiterman Pharma on Sale of Uractiv Portfolio to Terapia

PwC's Romanian affiliate D&B David and Baias has advised Fiterman Pharma on the sale of its Uractiv product portfolio to Sun Pharma company Terapia. KPMG Legal affiliate Toncescu si Asociatii reportedly advised the buyer.

NKO Partners Advises Dr. Max Group on Acquisition of K-Pharma

NKO Partners has advised the Dr. Max Group on another pharmacy chain acquisition in Serbia – that of Belgrade-based K-Pharma.

JDP Advises Boehringer Ingelheim on Establishing Shared Services Centre in Wroclaw

JDP Drapala & Partners has advised Boehringer Ingelheim on establishing a shared services center in Wroclaw.

CMS and Baker McKenzie Advise on Medicover’s Acquisition of McFit Polska from RSG Group

CMS has advised Medicover on its acquisition of McFit Polska from RSG Group. Baker McKenzie advised the seller.

Schoenherr Advises MedAustron on EIA for Treatment Room

Schoenherr has advised Austrian cancer treatment and research center MedAustron on the environmental impact assessment for the commissioning of a fourth treatment room.

Miray Turkmen Joins Organon as Legal & Compliance Lead

Miray Turkmen has joined pharmaceutical company Organon as its Legal & Compliance Lead, Turkey & South Africa.

Turkish Healthcare Agency Publishes Guidelines on Homeopathic Products

The Turkish Medicines and Medical Devices Agency ("Agency") published the Guideline on License Application for Homeopathic Medicinal Products (“Guideline on Licensing”) and the Guideline on the Packaging, Homeopathic Medicinal Product Information, Legibility and Tracking of Homeopathic Medicinal Products (“Guideline on Packaging”) on March 15, 2022. Both Guidelines are based on Homeopathic Medicinal Products Licensing Regulation (“Regulation”). Within the scope of the Guidelines, the Agency has started accepting license applications for homeopathic medicinal products through the website www.ebs.titck.gov.tr, as of April 1, 2022.